Location History:
- Bures sur Yvette, FR (2016)
- Paris, FR (2021 - 2024)
Company Filing History:
2 out of 154 
1 out of 64 
1 out of 1 
Years Active: 2016-2024
Title: The Innovative Contributions of Lionel Larue
Introduction
Lionel Larue is a prominent inventor based in Paris, France, known for his significant contributions to cancer research. With a total of three patents to his name, Larue has focused on groundbreaking methods for treating cancer by targeting specific cellular mechanisms.
Latest Patents
One of Larue's latest patents involves the inhibition of thymine DNA glycosylase in the treatment of cancer. This invention provides compositions, kits, and methods designed to induce growth arrest, differentiation, or senescence of cancer cells that express thymine DNA glycosylase. The methods include inhibiting the expression or biological activity of thymine DNA glycosylase in cancer cells. By doing so, the invention aims to induce cancer cells to revert to a healthy, non-cancerous phenotype or to enter a state of senescence. The types of cancer cells targeted by this method include melanoma, lung, prostate, pancreatic, ovarian, brain, colon, recto-sigmoid colon, and breast cancer cells.
Career Highlights
Throughout his career, Lionel Larue has worked with esteemed institutions such as Institut Curie and the Institute for Cancer Research. His work has been pivotal in advancing the understanding of cancer biology and developing innovative treatment strategies.
Collaborations
Larue has collaborated with notable colleagues in the field, including Alfonso Bellacosa and Rossella Tricarico. These partnerships have contributed to the depth and impact of his research.
Conclusion
Lionel Larue's innovative work in cancer treatment exemplifies the potential of targeted therapies in modern medicine. His patents reflect a commitment to improving patient outcomes and advancing scientific knowledge in oncology.